The Cuban company Heber Biotec and the U.S. company Mercurio Biotec join efforts to bring Heberprot-P therapy to patients who suffer from diabetic foot ulcer (DFU) in the United States, upon approval from the U.S. Food and Drug Administration (FDA).
According to the press note released by the entrepreneurial group BioCubaFarma, the Cuban therapy is expected to lower in more than half the current figure of risk of diabetic foot ulcer-related amputations in the United States, due to the successful history of the product and the commitment given by Mercurio and Heber.
Delegations from Cuba and the United States met to establish a Plan for Bilateral Coordination as part of the implementation of an Agreement signed by both countries in the field of cooperation on the preparedness and response to the pollution caused by discharges of hydrocarbons and other harmful or potentially hazardous substances in the Gulf of Mexico and the Florida Straits.
Authorities of the Aeronautical and Maritime Search and Rescue System of the Republic of Cuba (SAR-Cuba) participated in the observance of a tabletop exercise on search and rescue in Key West, Florida, in response to an invitation extended by the U.S. Coast Guard Service. The initiative, which took place on March 6, 2018, falls within the context of the bilateral governmental cooperation after the signing of an Agreement on this field on January 18, 2017.
Havana, March 5, 2018.- The decision by the United States Government, which unilaterally maintains the drawdown of its staff at the U.S. Embassy in Cuba indefinitely, is politically motivated and has no relation whatsoever with the safety and security of its officials in Havana, said the General Director for U.S. Affairs of the Cuban Foreign Ministry, Carlos Fernández de Cossío in his statement to the press.